Results for “”

Entry Author Date Location
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
Scholar Rock CEO Mahanthappa to Step Down, Kingsley Named Successor 07/14/20 Boston
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test 07/14/20 San Diego
Vor Biopharma Makes Slapak’s Chief Medical Officer Job Permanent 07/14/20 Boston
The 2020 National Xconomy Awards 07/14/20 Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
The 2020 National Xconomy Awards 07/14/20 National
New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health 07/14/20 Boston
Turning Point Names Centrexion’s Partridge as Chief Commercial Officer 07/13/20 San Diego
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
ViaCyte Taps Insulet’s Bradrick as Its First Chief Financial Officer 07/13/20 San Diego
Kiadis Pharma Brings On e-Therapeutics’ Barlow as Chief Business Officer 07/13/20 Europe
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
Cend Therapeutics Names Viracta’s David Slack As Its New President & CEO 07/09/20 San Diego
Kinnate Adds WuXi NextCODE’s Richard Williams as Chief Medical Officer 07/09/20 San Diego
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period 07/08/20 National
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Cyteir Adds Chief Scientific Officer & Chief Business Officer to C-Suite 07/07/20 Boston
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy 07/02/20 San Diego
Page 1 of 2136 next page »